Patents & Marketing Exclusivities.

Simplified explanation of pharma patents and pharma regulatory exclusivities with focus on US including:
1. Drug development timeline
2. Patent filing timeline
3. Generic application filing timeline
4. Patent term
5. Patent term Hatch-Waxman (H/W) extension
6. Patent term restoration or adjustment
7. Regulatory exclusivities
8. NCE exclisivity
9. New data exclusivity
10. Orphan drug exclusivity
11. Pediatric exclusivity
12. Difference in patent and regulatory exclusivities

#education
#training
#patent
#pharma
#industry
#regulatory
#intellectual
#intellectualproperty
#pharmaceutical


Disclaimer: This channel is for information purposes only for providing information on various topics related to pharma industry. The information in this channel is for education and information purposes only and should not be considered as any legal advice. One should always take legal advice before acting. This channel is not responsible for any loss or harm including monetary loss or any other type of loss or harm to any one based on actions taken on basis of this information or because of information given in this channel.